If you have poor immune resilience at 40, you're biologically closer to 55 — and a new study of 17,500 people shows this translates to a 69% greater chance of dying before age 70. But the same research found that those with strong immune resilience had up to a 15.5-year survival advantage. And what's emerging from the lab is that one well-studied molecule sits right at the center of this difference: creatine.
Most people think of creatine as a supplement for lifting weights or building muscle. But research presented at the Creatine Conference 2025 — along with a landmark 2025 study published in Aging Cell — reveals a more urgent story: your immune cells need creatine to function, and after 40, they're increasingly unable to get enough of it.
The 15.5-Year Survival Advantage You've Never Heard Of
Published April 23, 2025 in the journal Aging Cell, the study from UT Health San Antonio and the San Antonio Veterans Affairs Hospital is one of the most comprehensive longevity investigations ever conducted. Researchers analyzed immune and survival data from 17,500 individuals across multiple life stages and identified something they're calling "immune resilience" — and the results should be on the front page of every health publication.
People with strong immune resilience at age 40 had a 15.5-year survival advantage over those with weak resilience. Put differently: two people the same age, the same weight, with similar diets — but with different immune resilience — can expect dramatically different lifespans.
"Individuals with TCF7-linked immune resilience appear better equipped to resist inflammatory stressors and maintain a low-inflammatory immune profile promoting survival and better health," said Dr. Sunil K. Ahuja, the study's lead author and director of the Veterans Affairs Center for Personalized Medicine.
What Is TCF7 and Why Does It Matter After 40?
The key driver the researchers identified is a gene called TCF7 — T-cell factor 7. This gene controls the regeneration potential of T cells, the immune system's frontline fighters against infections, cancer cells, and chronic inflammation. Higher TCF7 expression is associated with T cells that stay young, active, and capable. Lower TCF7 means your T cells age prematurely, losing the ability to mount effective immune responses.
What makes this actionable is the study's finding that immune resilience is not fixed. It's measurable and modifiable — particularly during what the researchers called the "warranty period" of midlife, ages 40 to 70. After 70, the survival advantage begins to dissipate. That makes your 40s and 50s the most important window you have.
Three Immune Resilience Trajectories
By analyzing the 17,500 participants over time, the team identified three distinct patterns:
- Immune resilience preservers: Maintain high resilience even under inflammatory stress. These are the people who seem to age slowly and rarely get sick.
- Immune resilience reconstitutors: Experience temporary declines — after an infection, surgery, or high stress period — but recover. Their outcome is generally good if they actively support recovery.
- Immune resilience degraders: Show persistent loss of immune resilience over time, accumulating what the researchers call a "pathogenic triad" of chronic inflammation, immune system aging, and cellular senescence.
The difference between becoming a "preserver" and a "degrader" isn't purely genetic. The study found that diet, exercise, medications, and future immunotherapies can shift your trajectory. That means the choices you make in your 40s have outsized consequence.
The Energy Crisis Inside Your Immune Cells
Here's what most coverage of immune health after 40 misses: your immune cells have enormous energy demands. When a T cell encounters a threat — a tumor cell, a virus, a bacterium — it needs to rapidly produce ATP, divide, migrate, and release signaling molecules. It's an incredibly energy-intensive process.
And this is where creatine enters the picture in a way that goes far beyond the gym.
Research presented at the 2025 Creatine Conference by Dr. Lili Yang at the University of California, Los Angeles revealed that tumor-infiltrating immune cells — the CD8+ T cells that are your body's primary cancer-fighting cells — express high levels of the creatine transporter (SLC6A8). In other words, your T cells are actively trying to import creatine. They need it.
When Dr. Yang's team deleted the creatine transporter specifically from CD8+ T cells in mouse models, those T cells failed to control tumor growth. They showed impaired proliferation, reduced production of effector molecules, and accelerated exhaustion. The core problem was energy: without the ability to import creatine, T cells had lower intracellular ATP.
"The phosphocreatine/creatine kinase system acts as a metabolic battery that helps T cells sustain the high energy demands of an effective anti-tumor response," Dr. Yang explained at the conference.
Creatine Supplementation Slowed Tumor Growth in Animal Models
When researchers supplemented creatine in tumor-bearing mice — either by injection or in the diet — tumor growth slowed measurably, and CD8+ T cell activity inside the tumors increased. The effect was dependent on functional T cells; it disappeared in mice depleted of CD8+ T cells.
Perhaps most significant: combining creatine with anti-PD-1 immunotherapy produced the strongest anti-tumor effects of all conditions tested. This suggests creatine may not just support immune function on its own — it may amplify the effectiveness of medical immune therapies.
A 2026 study published in iScience by the same lab found that dendritic cells — which are responsible for signaling T cells and initiating the immune response against cancer — also benefit significantly from creatine-derived energy. Two distinct anti-tumor immune cell types now appear to depend on creatine availability.
The Gut Connection: How Creatine Quiets Inflammation
A second line of research, presented by Dr. Kristen Drescher of Creighton University, approached immune health from a different angle: the gut microbiome.
In mouse models of multiple sclerosis (autoimmune neuroinflammation), Dr. Drescher's team found that creatinine — a metabolite of creatine — significantly shifted the gut microbiome toward an anti-inflammatory profile. Animals given creatinine had lower levels of Proteobacteria (linked to gut barrier dysfunction), decreased Parasutterella (associated with chronic inflammation), and increased butyrate-producing bacteria that support gut integrity and systemic immune regulation.
The result was striking: at day 7 of viral infection, treated mice showed substantially less brain inflammation. By day 35, during the autoimmune phase, control mice had abundant T cells invading the spinal cord white matter. In creatinine-treated mice, that damage was almost entirely absent.
While humans aren't mice, the mechanism is biologically compelling: creatine's metabolite appears to shift the gut microbiome in ways that dampen the very kind of chronic, low-grade inflammation that the 2025 UT Health San Antonio study identified as the primary force eroding immune resilience in midlife.
🧪 ATO Health Creatine — Formulated for Adults Over 40
Micronized creatine monohydrate. No fillers, no creatine HCl gimmicks — just the form backed by 200+ studies, now linked to immune cell energy and T-cell function.
Why Your 40s Are the Immune Resilience Window You Can't Afford to Miss
The UT Health San Antonio study made one thing emphatically clear: the protective effects of immune resilience begin to wane around age 70. The researchers call this "failed salutogenesis" — a point at which the biological infrastructure supporting immune recovery becomes too degraded to repair efficiently.
That means the work you do in your 40s and 50s isn't just about feeling better now. It's about determining which of the three immune trajectories you'll follow for the next three decades.
What shifts your trajectory? The study highlighted four categories of modifiable factors:
- Resistance exercise: Consistently shown to upregulate TCF7 expression and maintain T-cell regenerative capacity
- Diet quality: Particularly anti-inflammatory dietary patterns that reduce the chronic inflammatory load on immune cells
- Metabolic support: Ensuring immune cells have sufficient ATP substrate — which is where creatine's role becomes practical
- Stress reduction: Chronic psychological stress suppresses TCF7 expression and accelerates immune aging
What This Means For You: Specific Action Steps
This research translates into a clear framework for adults in their 40s and 50s who want to maintain immune resilience through the critical window:
1. Prioritize resistance training 3-4x per week. Both the immune resilience study and the T-cell research point to physical activity — particularly muscle-building exercise — as one of the strongest drivers of T-cell health and TCF7 expression. You're not just building muscle; you're training your immune system.
2. Add 3-5g of creatine monohydrate daily. The dosage used in human safety studies — and the amount shown to saturate creatine transporters in muscle — is 3 to 5 grams per day. At that dose, creatine has a safety record spanning decades. For immune cell energy support, consistent daily supplementation matters more than timing. ATO Health Creatine delivers pure micronized creatine monohydrate — the exact form used in research — without additives or fillers.
3. Eat for your microbiome. Given that creatine's metabolite creatinine appears to shift the gut toward less inflammation, your dietary microbiome strategy matters. High-fiber foods, fermented foods, and minimizing ultra-processed food are the three interventions with the most consistent evidence for butyrate production and gut barrier integrity.
4. Track inflammatory stress events. The research found that infections, surgeries, and high-stress periods temporarily reduce immune resilience. What separates reconstitutors from degraders is recovery speed. Prioritizing sleep and nutrition during and after stressors keeps you on the resilience trajectory.
Frequently Asked Questions
Q: What is immune resilience and how is it different from just having a strong immune system?
A: Immune resilience specifically refers to your immune system's ability to maintain low-level inflammation while still mounting effective responses to threats. The 2025 Aging Cell study showed it's governed by TCF7, a gene that keeps T cells young and regenerative. You can have immune cells that react vigorously to threats (a strong response) while still having poor immune resilience if they also drive chronic inflammation and exhaust quickly.
Q: Can creatine actually improve immune function, or is the evidence only in animals?
A: The direct evidence linking creatine to T-cell tumor-fighting is currently from animal models, as presented at the Creatine Conference 2025. However, the biological mechanism — creatine as an ATP buffer in immune cells — is well-established in human cell biology. Human T cells express the same creatine transporter (SLC6A8). Clinical trials combining creatine with immunotherapy are now underway based on these preclinical results.
Q: What is the right dose of creatine for immune health after 40?
A: The standard dose used across virtually all human creatine research is 3 to 5 grams per day of creatine monohydrate. This is consistent with the dose discussed at the Creatine Conference 2025 and in the Frontiers in Nutrition 2025 safety review. No evidence suggests higher doses provide additional benefit for general health in non-athletes.
Q: What is TCF7 and can you increase it naturally?
A: TCF7 (T-cell factor 7) is a transcription factor that maintains the stem-like regenerative capacity of T cells. Research suggests it can be upregulated by regular resistance exercise, adequate sleep, and reducing chronic inflammatory burdens. The 2025 study found that lifestyle factors remain powerful modulators of TCF7 expression well into middle age.
Q: Does everyone's immune resilience decline after 40?
A: Not inevitably. The 2025 UT Health San Antonio study identified three distinct trajectories: preservers (who maintain high resilience), reconstitutors (who dip but recover), and degraders (who show persistent decline). The research specifically found that the 40-70 age window is biologically modifiable — meaning your actions during this period have a measurable impact on which trajectory you follow.
Q: Is creatine safe to take long-term for adults over 40?
A: Yes. A comprehensive 2025 safety review published in the Journal of the International Society of Sports Nutrition — analyzing adverse event reports and clinical trials — found creatine monohydrate to be well-tolerated with no clinically significant side effects at standard doses. It is one of the most extensively studied dietary supplements in history, with consistent safety findings across more than 200 human trials.
Sources & Further Reading
- Manoharan MS, Lee GC, Harper N, et al. "The 15-Year Survival Advantage: Immune Resilience as a Salutogenic Force in Healthy Aging." Aging Cell, April 23, 2025. doi:10.1111/acel.70063
- Di Biase S, et al. "Creatine uptake regulates CD8 T cell antitumor immunity." Journal of Experimental Medicine, 2019; 216(12):2869–2882.
- Kang E, et al. "Creatine uptake enhances dendritic cell activation and antitumor immunity." iScience, 2026; 29(4):115436.
- Bredahl EC, et al. "The Role of Creatine in the Development and Activation of Immune Responses." Nutrients, 2021; 13(3):751.
- Kreider RB, et al. "Safety of creatine supplementation: analysis of the prevalence of reported side effects in clinical trials and adverse event reports." J Int Soc Sports Nutr, 2025; 22(sup1):2488937.
- Creatine Conference 2025 — presentations by Prof. Lili Yang (UCLA) and Prof. Kristen Drescher (Creighton University). Organized by Creatine for Health Scientific Advisory Board.